DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. However, there have been few studies which detail such a rapid progression of microhemorrhages in this patient population as well as such a late progression of the disease.

Arterioles 40

Arterioles Cerebrovascular Disease Outpatient Document 40

Cardiomatics

AUGUST 4, 2022

Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease. In Poland, this problem looks similar: the main cause of death are cardiovascular diseases.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Coronary Artery Disease 52

DAIC

FEBRUARY 7, 2024

During the American Stroke Association’s International Stroke Conference 2024, ISC24, eleven scientists leading the way in stroke research will be recognized for their exceptional professional achievements. Sacco Outstanding Stroke Research Mentor Award, which honors Ralph L. 7-9 in Phoenix, AZ. Sacco, M.D.,

Stroke 105

Stroke Strokes Research Health Disparities 105

DAIC

JANUARY 22, 2024

The International Stroke Conference 2024 will be held Feb. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

Stroke 100

Stroke Strokes Hospital Stents 100

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AHUP2-AHUP2, February 1, 2025. Introduction:Cerebrovascular disease, a leading cause of death in the U.S., This study used deidentified, publicly available data and was deemed not human research by the University of Nevada, Reno IRB.Results:From 1999 to 2020, the overall U.S.

Cerebrovascular Disease 40

Cerebrovascular Disease Public Health Certification Document 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A109-A109, February 1, 2025. Introduction:Cerebrovascular disease, a leading cause of death in the U.S., This study used deidentified, publicly available data and was deemed not human research by the University of Nevada, Reno IRB.Results:From 1999 to 2020, the overall U.S.

Cerebrovascular Disease 40

Cerebrovascular Disease Public Health Certification Document 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP313-AWP313, February 1, 2025. Introduction:In mid- to high-latitude regions, cerebrovascular diseases (CBVD) are known to peak during the winter. Seasonality and climate factors can be considered predisposing risk factors for cerebrovascular disease.

Cerebrovascular Disease 40

Cerebrovascular Disease Risk Factors Document Obesity 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP248-ATP248, February 1, 2024. Background:Diabetes is a highly heritable stroke risk factor with numerous known genetic risk variants. However, the role of these genetic risk variants in the development of cerebrovascular disease in Native Hawaiians remains unknown. 2.05; p=0.04).Conclusions:Among

Genetic predisposition 40

Genetic predisposition Diabetes Stroke Strokes 40

Dr. Smith's ECG Blog

APRIL 8, 2015

Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. to 3.80).

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

Frontiers in Cardiovascular Medicine

JANUARY 8, 2025

ObjectiveThis meta-analysis aims to evaluate the safety and efficacy of indobufen in the treatment of cardiovascular diseases, cerebrovascular diseases, and thromboembolic disorders. The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and adverse reactions.

Cerebrovascular Disease 52

Cerebrovascular Disease Cardiovascular Disease Myocardial Infarction Angina 52

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.

Cardiovascular Disease 59

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Thrombosis 59